Walgreens Boots Alliance (NASDAQ:WBA) Raised to “Hold” at Wolfe Research

Wolfe Research upgraded shares of Walgreens Boots Alliance (NASDAQ:WBAFree Report) to a hold rating in a research report sent to investors on Monday,Zacks.com reports.

WBA has been the subject of a number of other reports. Truist Financial decreased their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a report on Friday, January 31st. Evercore ISI boosted their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research report on Monday, January 13th. Royal Bank of Canada increased their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research note on Wednesday, January 15th. Finally, Bank of America lifted their price objective on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research note on Monday, January 13th. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, Walgreens Boots Alliance currently has an average rating of “Hold” and an average target price of $12.63.

View Our Latest Research Report on Walgreens Boots Alliance

Walgreens Boots Alliance Stock Performance

Shares of WBA opened at $10.82 on Monday. The firm has a fifty day moving average of $10.38 and a 200-day moving average of $9.70. The company has a market cap of $9.35 billion, a price-to-earnings ratio of -1.06, a price-to-earnings-growth ratio of 1.31 and a beta of 0.65. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. Walgreens Boots Alliance has a 1 year low of $8.08 and a 1 year high of $22.05.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last issued its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The firm had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. During the same period last year, the firm posted $0.66 EPS. Walgreens Boots Alliance’s quarterly revenue was up 7.6% compared to the same quarter last year. As a group, equities analysts anticipate that Walgreens Boots Alliance will post 1.6 earnings per share for the current year.

Hedge Funds Weigh In On Walgreens Boots Alliance

Large investors have recently made changes to their positions in the business. First Financial Corp IN raised its holdings in shares of Walgreens Boots Alliance by 49.2% in the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after purchasing an additional 885 shares in the last quarter. Golden State Wealth Management LLC acquired a new position in Walgreens Boots Alliance in the fourth quarter worth approximately $26,000. Riverview Trust Co increased its holdings in shares of Walgreens Boots Alliance by 123.8% in the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator’s stock valued at $27,000 after buying an additional 1,590 shares in the last quarter. Colonial Trust Co SC lifted its position in shares of Walgreens Boots Alliance by 79.5% during the 4th quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator’s stock valued at $27,000 after acquiring an additional 1,297 shares during the last quarter. Finally, Venturi Wealth Management LLC purchased a new stake in shares of Walgreens Boots Alliance during the fourth quarter valued at $28,000. Institutional investors own 58.59% of the company’s stock.

About Walgreens Boots Alliance

(Get Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Featured Stories

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.